Division of Pediatric Pulmonary and Allergy, University of Maryland School of Medicine, Baltimore, Maryland.
Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ann Allergy Asthma Immunol. 2019 Apr;122(4):381-386. doi: 10.1016/j.anai.2019.02.002. Epub 2019 Feb 10.
Intensive care unit (ICU) admission is a risk factor for fatal asthma. Little is known about risk factors for pediatric ICU admissions for asthma.
To examine characteristics of underserved minority children with prior ICU admissions for asthma.
Baseline survey data, salivary cotinine levels, and allergen specific IgE serologic test results were obtained from children with uncontrolled asthma enrolled in a randomized clinical trial of a behavioral education environmental control intervention. Characteristics of children with and without prior ICU admission were compared using χ and t tests. Logistic regression assessed significance of higher odds of prior ICU admission comparing factor-level categories.
Patients included 222 primarily African American (93.7%), male (56%), Medicaid-insured (92.8%) children with a mean (SD) age of 6.4 (2.7) years with uncontrolled asthma. Most (57.9%) had detectable cotinine levels, 82.6% were sensitized to more than 1 environmental allergen, and 27.9% had prior ICU admissions. Prior ICU patients were more likely to be very poor (<$10,000 per year) and sensitized to more than 1 allergen tested (most importantly mouse) (P < .05). Allergen sensitization in the groups did not differ for cockroach, cat, dog, Alternaria, Aspergillus, dust mite, grass, or tree. Although more ICU patients received combination controller therapy, they also overused albuterol. Only 27.4% of ICU patients received specialty care in the previous 2 years, which was not significantly different from non-ICU patients.
Children with high mortality risk, including history of ICU admission, were twice as likely to live in extreme poverty, have atopy (particularly mouse allergen), use combination controller therapy, and overuse albuterol.
ClinicalTrials.gov Identifier: NCT01981564.
入住重症监护病房(ICU)是致命性哮喘的一个危险因素。然而,对于儿科 ICU 收治的哮喘患者的危险因素,我们知之甚少。
研究先前因哮喘入住 ICU 的服务欠缺少数族裔儿童的特征。
对参加一项行为教育环境控制干预随机临床试验的未得到控制的哮喘儿童进行基线调查、唾液可替宁水平检测以及过敏原特异性 IgE 血清学检测。采用卡方检验和 t 检验比较有无 ICU 住院史儿童的特征。采用 logistic 回归比较各因素水平的 ICU 住院史比值比。
研究共纳入 222 例主要为非洲裔美国人(93.7%)、男性(56%)、受医疗补助保险(92.8%)的儿童,平均(SD)年龄为 6.4(2.7)岁,均患有未得到控制的哮喘。大多数(57.9%)儿童的可替宁水平可检测到,82.6%的儿童对 1 种以上环境过敏原致敏,27.9%的儿童有过 ICU 住院史。与无 ICU 住院史的患者相比,有 ICU 住院史的患者更可能来自极度贫困家庭(<$10,000 美元/年),并且对更多种过敏原致敏(最重要的是对鼠类)(P<.05)。两组的蟑螂、猫、狗、交链孢霉、烟曲霉、尘螨、草和树过敏原致敏情况无差异。尽管 ICU 住院患者更多地接受联合控制药物治疗,但他们也过度使用沙丁胺醇。只有 27.4%的 ICU 住院患者在过去 2 年内接受过专科治疗,这与非 ICU 住院患者无显著差异。
有高死亡率风险的儿童,包括有 ICU 住院史的儿童,更有可能生活在极度贫困中,患有特应性疾病(尤其是对鼠类过敏),接受联合控制药物治疗,并且过度使用沙丁胺醇。
ClinicalTrials.gov 标识符:NCT01981564。